Publication: Nitric oxide and aggressive behavior of lung cancer cells
Submitted Date
Received Date
Accepted Date
Issued Date
2015-01-01
Copyright Date
Announcement No.
Application No.
Patent No.
Valid Date
Resource Type
Edition
Resource Version
Language
File Type
No. of Pages/File Size
ISBN
ISSN
02507005
eISSN
DOI
Scopus ID
WOS ID
Pubmed ID
arXiv ID
Call No.
Other identifier(s)
2-s2.0-84939628326
Journal Title
Volume
Issue
item.page.oaire.edition
Start Page
End Page
Access Rights
Access Status
Rights
Mahidol University
Rights Holder(s)
SCOPUS
Physical Location
Bibliographic Citation
Anticancer Research. Vol.35, No.9 (2015), 4585-4592
Citation
Sudjit Luanpitpong, Pithi Chanvorachote (2015). Nitric oxide and aggressive behavior of lung cancer cells. Retrieved from: https://repository.li.mahidol.ac.th/handle/20.500.14594/35610.
Research Projects
Organizational Units
Authors
Journal Issue
Thesis
Title
Nitric oxide and aggressive behavior of lung cancer cells
Alternative Title(s)
Author(s)
Author's Affiliation
Author's E-mail
Editor(s)
Editor's Affiliation
Corresponding Author(s)
Creator(s)
Compiler
Advisor(s)
Illustrator(s)
Applicant(s)
Inventor(s)
Issuer
Assignee
Other Contributor(s)
Series
Has Part
Abstract
Nitric oxide (NO) is an important cell signaling molecule whose level is frequently elevated in many tumors including that of lung. Cellular phenotypes and behaviors are influenced by NO found in proximity to the tumor, namely the tumor microenvironment. In lung cancer, a high level of NO is linked to advanced stage and poor survival of patients. This review describes the promotory role of NO in aggressive behavior of lung cancer cells with a focus on apoptosis and anoikis resistance, cell migration and invasion and cancer stem cells, all of which are key determinants of cancer relapse and metastasis. We specifically address the effects of NO on the modulations of structure, stability, function and activity of key proteins, and discuss how these changes could affect aggressive behavior. Such knowledge will encourage additional experimental and clinical investigations that contribute to the understanding of the molecular basis of cancer pathophysiology which could lead to targeted cancer therapy.